Cube Click Secures FDA Approval for SMILE Dx

The U.S. Food and Drug Administration (FDA) has approved Cube Click Inc.’s flagship medical device, SMILE Dx, a next-generation artificial intelligence (AI)-powered diagnostic platform that identifies cavities (caries), root canals (periapical radiolucencies), and periodontal disease at the radiographic pixel level.

“The Dental AI imaging market is growing at a compound annual growth rate (CAGR) of 22.3%. If SMILE Dx captures just 2% of this $3.1 billion market, that translates to $62 million in annual revenue,” Cube Click CEO Dr. Richard Ricci said. “At a conservative 5x revenue multiple, SMILE Dx could command a $310 million valuation. Under a more optimistic 10x multiple, that valuation rises to $620 million, highlighting the significant upside potential for early investors.”

According to the FDA, dentists routinely misdiagnose more than 20% of cavities and root canal pathologies. SMILE Dx directly addresses this challenge, delivering an average 19% improvement in diagnostic detection, as confirmed by multiple clinical studies. The platform’s cloud-based AI system not only enhances clinical outcomes but also drives practice growth by increasing patient engagement and acceptance of treatment plans.

Investment highlights:

• The first and only FDA-approved dental AI device compatible with both digital and phosphor plate sensors.
• The First and only FDA-approved system for detecting primary, secondary, and gross caries.
• Six awarded U.S. patents and three pending patents, reinforcing strong intellectual property protection.
• Cloud-based recurring revenue model, positioned for rapid market penetration and scale.

“SMILE Dx represents a significant market disruptor,” Cube Click Chief Financial Officer Dr. Andrea Cambria stated. “By dramatically improving diagnostic accuracy and treatment acceptance rates, we are unlocking substantial new revenue streams for dental practices—while creating a highly scalable, subscription-based business model for Cube Click.”

Cube Click Inc. develops advanced AI-powered medical devices that help improve dental diagnostic precision.